At the time of writing, Portage Biotech Inc [PRTG] stock is trading at $10.77, up 27.46%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PRTG shares have gain 18.48% over the last week, with a monthly amount glided 128.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, H.C. Wainwright started tracking the stock with Buy rating on March 07, 2022, and set its price target to $32. On September 21, 2021, Oppenheimer initiated with a Outperform rating and assigned a price target of $30 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $40 on September 02, 2021. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $35 as its price target on August 19, 2021.
For the past year, the stock price of Portage Biotech Inc fluctuated between $2.10 and $23.01. Currently, Wall Street analysts expect the stock to reach $4.88 within the next 12 months. Portage Biotech Inc [NASDAQ: PRTG] shares were valued at $10.77 at the most recent close of the market. An investor can expect a potential drop of -54.69% based on the average PRTG price forecast.
Analyzing the PRTG fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -24.86, Equity is -6.74 and Total Capital is -6.41. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.71 points at the first support level, and at 8.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.67, and for the 2nd resistance point, it is at 12.57.
Ratios To Look Out For
It is important to note that Portage Biotech Inc [NASDAQ:PRTG] has a current ratio of 3.08. Also, the Quick Ratio is 3.08, while the Cash Ratio stands at 2.02.
Transactions by insiders
Recent insider trading involved Allan L. Shaw, Affiliate, that happened on Oct 03 ’24 when 882.0 shares were purchased. Affiliate, Allan L. Shaw completed a deal on Sep 27 ’24 to buy 10761.0 shares. Meanwhile, Director Steven Mintz bought 6545.0 shares on Sep 18 ’24.
